"Evaluation of Pathogen Reduction Systems to Inactivate Dengue and Chikungunya Viruses in Apheresis Platelets Suspended in Plasma"
written by Li Kiang Tan, Sally Lam, Swee Ling Low, Fang Hui Tan, Lee Ching Ng, Diana Teo,
published by Advances in Infectious Diseases, Vol.3 No.1, 2013
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] The Emergence of Zoonotic Pathogens as Agents of Concern in Transfusion Medicine
Blood Safety, 2019
[2] A systematic review of individual and community mitigation measures for prevention and control of chikungunya virus
2019
[3] Amustaline (S‐303) treatment inactivates high levels of Chikungunya virus in red‐blood‐cell components
Vox Sanguinis, 2018
[4] SYBR green-based one step quantitative real-time polymerase chain reaction assay for the detection of Zika virus in field-caught mosquitoes
2017
[5] Inactivation of Zika virus in platelet components using amotosalen and ultraviolet A illumination
Transfusion, 2017
[6] Pathogen inactivation of Dengue virus in red blood cells using amustaline and glutathione
Transfusion, 2017
[7] Inactivation of Z ika virus in plasma with amotosalen and ultraviolet A illumination
Transfusion, 2016
[8] Dengue virus persists and replicates during storage of platelet and red blood cell units
Transfusion, 2016
[9] 혈소판제제에 대한 병원체 불활화
대한수혈학회지: 제, 2016
[10] Pathogen Reduction for Platelets
The Korean Journal of Blood Transfusion, 2016
[11] Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical use
Blood Transfusion, 2016
[12] Zika Virus and the Blood Supply: What Do We Know?
Transfusion Medicine Reviews, 2016
[13] Prevention of transfusion‐transmitted Zika virus in French Polynesia, nucleic acid testing versus pathogen inactivation
ISBT Science Series, 2016
[14] Inactivation of viruses in platelet and plasma products using a riboflavin‐and‐UV–based photochemical treatment
Transfusion, 2015
[15] Inactivation of Zika virus in plasma with amotosalen and ultraviolet A illumination
Transfusion, 2015
[16] Reflections on the emergence of chikungunya virus in the United States: time to revisit a successful paradigm for the safety of blood‐derived therapies
Transfusion, 2015
[17] Pathogen inactivation: emerging indications
Current Opinion in Hematology, 2015
[18] Reflections on the emergence of chikungunya virus in the U nited S tates: time to revisit a successful paradigm for the safety of blood‐derived therapies
Transfusion, 2015
[19] Pathogen inactivation efficacy of Mirasol PRT System and Intercept Blood System for non‐leucoreduced platelet‐rich plasma‐derived platelets suspended in plasma
Vox sanguinis, 2014
[20] Inactivation of dengue virus in plasma with amotosalen and ultraviolet A illumination
Transfusion, 2014